🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to investigate the effects of oral psilocybin on OCD sympto...
Status
Completed
Location
Connecticut Mental Health Center
Start Date
2018-11-13
Trial ID
NCT03356483
Treatments Being Tested
The study is a randomized, double-blind, placebo-controlled, expectancy-con...
Status
Not Yet Recruiting
Location
Connecticut Mental Health Center
Start Date
2026-08-31
Trial ID
NCT07693153
Treatments Being Tested
MLS101 is being developed as a low dose psilocybin, that can be administere...
Status
Completed
Location
CMAX Clinical Research
Start Date
2024-11-08
Trial ID
NCT06643637
Treatments Being Tested
Psilocybin is a classic serotonergic hallucinogen acting on the 5-HT2A rece...
Status
Completed
Location
University Hospital Basel, Clinical Trial Unit
Start Date
2019-07-04
Trial ID
NCT03912974
Treatments Being Tested
This trial aims to examine the safety and efficacy of small (2mg) sub-hallu...
Status
Completed
Location
Psych Research
Start Date
2023-07-15
Trial ID
NCT05259943
Treatments Being Tested
The goal of this clinical trial is to learn whether certain methods of dete...
Status
Unknown
Location
Multiple Locations
Start Date
2024-11
Trial ID
NCT06529939
Treatments Being Tested
This is a randomised double-blind clinical trial. The aim is to compare the...
Status
Completed
Location
Imperial College Hammersmith campus
Start Date
2019-01-07
Trial ID
NCT03429075
Treatments Being Tested
The purpose of this study is to determine the efficacy, safety and tolerabi...
Status
Recruiting
Location
UAB Psychiatry and Behavioral Neurology
Start Date
2025-12-10
Trial ID
NCT06793397
Treatments Being Tested
The aim of the study is to identify neural signatures, behavioral and pheno...
Status
Completed
Location
Multiple Locations
Start Date
2013-10-01
Trial ID
NCT03736980
Treatments Being Tested
The purpose of the present study is to evaluate the feasibility, initial si...
Status
Withdrawn
Location
University of Alabama at Birmingham
Start Date
2023-08-15
Trial ID
NCT05227742
Treatments Being Tested